Last Updated: June 22, 2026

PRAMIPEXOLE Drug Patent Profile

Name: PRAMIPEXOLE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Pramipexole, and when can generic versions of Pramipexole launch?

Pramipexole is a drug marketed by Actavis Elizabeth, Alembic, Chartwell Rx, Dr Reddys, Macleods Pharms Ltd, Novast Labs, Ph Health, Xiamen Lp Pharm Co, Zydus Pharms, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Heritage Pharma Avet, Natco, Natco Pharma, Pharmobedient, Rising, Sandoz, Sciegen Pharms, Strides Pharma, Sun Pharm Inds Inc, Torrent Pharms, Unichem, and Zydus Pharms Usa Inc. and is included in thirty NDAs.

The generic ingredient in PRAMIPEXOLE is pramipexole dihydrochloride. There are twenty-five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pramipexole dihydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Pramipexole

A generic version of PRAMIPEXOLE was approved as pramipexole dihydrochloride by ZYDUS PHARMS USA INC on July 6^th, 2010.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PRAMIPEXOLE?
What are the global sales for PRAMIPEXOLE?
What is Average Wholesale Price for PRAMIPEXOLE?

Summary for PRAMIPEXOLE

US Patents:	0
Applicants:	23
NDAs:	30
Drug Prices:	Drug price information for PRAMIPEXOLE
Drug Sales Revenues:	Drug sales revenues for PRAMIPEXOLE
DailyMed Link:	PRAMIPEXOLE at DailyMed

Drug patent expirations by year for PRAMIPEXOLE

US Patents and Regulatory Information for PRAMIPEXOLE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Pharms Ltd	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	090781-001	Oct 8, 2010	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Natco	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	077854-003	Oct 8, 2010		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ph Health	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE;ORAL	202206-003	Feb 6, 2014		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Novast Labs	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE;ORAL	213444-001	Feb 3, 2022	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Zydus Pharms Usa Inc	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	078920-002	Jul 6, 2010	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.